HP-1007

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameHP-1007
Drug Alias Namerosuvastatin + omega 3 acid ethyl ester (Hanmi)rosuvastatin + omega-3 polunsaturated fatty acid derivatives (Hanmi)HCP-1007
ClassificationSmall molecules
Mechanisms of ActionHMG-CoA reductase inhibitors
TargetsHMG-CoA reductase
Therapy Area/IndicationsHyperlipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHanmi Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsHyperlipidemias

Other Information

ATC CodeN/A
Related LinksN/A